Literature DB >> 25369778

Update on Greenlight laser vaporization (PVP) 2014.

Malte Rieken1, Alexander Bachmann.   

Abstract

PURPOSE: To asses the (1) outcomes and (2) intraoperative, perioperative, and long-term complications of photoselective vaporization of the prostate (PVP) with Greenlight laser.
METHODS: A systematic review of outcomes and complications of PVP was conducted. The article selection process was performed according to PRISMA guidelines and included publications published between 2009 and 2014.
RESULTS: All generations of PVP (80, 120, 180 W) lead to a significant improvement of micturition symptoms (IPSS, QoL) and voiding parameters (Q max, PVR volume) during follow-up. Data on sexual function are heterogeneous and suggest a trend toward decline in erectile function in men with sustained preoperative erection. The rate of intraoperative complications is low. Data on peri- and postoperative complications show a large variation that mainly can be attributed to heterogeneity in documentation.
CONCLUSIONS: PVP leads to a statistically significant and clinically relevant improvement of voiding parameters and micturition symptoms in patients with prostates <100 ml. The technique is characterized by a high degree of intra- and perioperative safety. Long-term evidence on functional outcomes and complications beyond 3 years from RCTs is currently missing for all generations of the Greenlight laser.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25369778     DOI: 10.1007/s00345-014-1437-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  26 in total

1.  180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters.

Authors:  Pierre-Alain Hueber; Daniel Liberman; Tal Ben-Zvi; Henry Woo; Mahmood A Hai; Alexis E Te; Bilal Chughtai; Richard Lee; Matthew Rutman; Ricardo R Gonzalez; Neil Barber; Naif Al-Hathal; Talal Al-Qaoud; Quoc-Dien Trinh; Kevin C Zorn
Journal:  Urology       Date:  2013-10-25       Impact factor: 2.649

2.  180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.

Authors:  Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas
Journal:  Eur Urol       Date:  2013-11-11       Impact factor: 20.096

3.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.

Authors:  Carlos Capitán; Cristina Blázquez; M Dolores Martin; Virginia Hernández; Enrique de la Peña; Carlos Llorente
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

4.  Photoselective vaporization of the prostate using the 180W lithium triborate laser.

Authors:  Amanda S J Chung; Charles Chabert; Hin-Wai Yap; Jimmy Lam; Nader Awad; Fadi Nuwayhid; Frank Redwig; Prem Rashid; Henry H Woo
Journal:  ANZ J Surg       Date:  2012-03-28       Impact factor: 1.872

5.  A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: a single center experience.

Authors:  Anup Kumar; Pawan Vasudeva; Niraj Kumar; Biswajit Nanda; Sanjeev K Jha; Nayhan Mohanty
Journal:  J Endourol       Date:  2013-09-19       Impact factor: 2.942

6.  Evaluation of the Effect of Photoselective Vaporization of the Prostate on Sexual Function in a Prospective Study: A Single Center Experience of 150 Patients.

Authors:  Anup Kumar; Pawan Vasudeva; Niraj Kumar; Biswajit Nanda; Nayan K Mohanty
Journal:  J Endourol       Date:  2012-10-09       Impact factor: 2.942

Review 7.  Laser treatment of benign prostate enlargement--which laser for which prostate?

Authors:  Malte Rieken; Alexander Bachmann
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

Review 8.  A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.

Authors:  Jean-Nicolas Cornu; Sascha Ahyai; Alexander Bachmann; Jean de la Rosette; Peter Gilling; Christian Gratzke; Kevin McVary; Giacomo Novara; Henry Woo; Stephan Madersbacher
Journal:  Eur Urol       Date:  2014-06-25       Impact factor: 20.096

9.  Photoselective vaporization of prostate vs. transurethral resection of prostate: A prospective, randomized study with one year follow-up.

Authors:  Nayan K Mohanty; Pawan Vasudeva; Anup Kumar; Sanjay Prakash; Manoj Jain; Rajender P Arora
Journal:  Indian J Urol       Date:  2012-07

10.  Early experience photoselective vaporisation of the prostate using the 180W lithium triborate and comparison with the 120W lithium triborate laser.

Authors:  Nicholas A Campbell; Amanda S J Chung; Peter D Yoon; Isaac Thangasamy; Henry H Woo
Journal:  Prostate Int       Date:  2013-02-04
View more
  8 in total

1.  Absorption of irrigation fluid during XPS™ GreenLight laser vaporization of the prostate: results from a prospective breath ethanol monitoring study.

Authors:  Marian S Wettstein; Cédric Poyet; Nico C Grossmann; Christian D Fankhauser; Etienne X Keller; Marko Kozomara; Salome Meyer; Tullio Sulser; Alexander Müller; Thomas Hermanns
Journal:  World J Urol       Date:  2016-01-16       Impact factor: 4.226

2.  Update on lasers in urology 2015.

Authors:  Thomas R W Herrmann; Thorsten Bach
Journal:  World J Urol       Date:  2015-04       Impact factor: 4.226

3.  [Long-term results after prostate vaporisation : GreenLight™ laser vaporisation of the prostate and electrovaporisation].

Authors:  M Rieken; A Bachmann; S F Shariat
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

Review 4.  [Surgical treatment of benign prostatic hyperplasia-resection, vaporization or enucleation?]

Authors:  M Rieken; T R W Herrmann; C Füllhase
Journal:  Urologe A       Date:  2019-03       Impact factor: 0.639

5.  Impact of different color fiber sleeves on beam hazards of 532-nm laser and vaporization efficiency.

Authors:  Jian-Long Wang; Miao Wang; Jian-Ye Wang; Ben Wan; Da-Lei Zhang; Hui-Min Hou; Xiao-Xiao Guo; Ling-Feng Meng; Ming Liu
Journal:  Lasers Med Sci       Date:  2018-10-23       Impact factor: 3.161

6.  Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up.

Authors:  S Cimino; S Voce; F Palmieri; V Favilla; T Castelli; S Privitera; R Giardina; G Reale; G I Russo; G Morgia
Journal:  Int J Impot Res       Date:  2017-08-17       Impact factor: 2.896

7.  Is loss of power output due to laser fiber degradation still an issue during prostate vaporization using the 180 W GreenLight XPS laser?

Authors:  Thomas Hermanns; Nico C Grossmann; Marian S Wettstein; Etienne X Keller; Christian D Fankhauser; Oliver Gross; Benedikt Kranzbühler; Martin Lüscher; Alexander H Meier; Tullio Sulser; Cédric Poyet
Journal:  World J Urol       Date:  2018-06-19       Impact factor: 4.226

8.  Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance.

Authors:  Ghalib Jibara; Daniel D Sjoberg; Gillian L Stearns; Yariv Stabholz; Ali Fathollahi; Laura S Leddy; Nicole Benfante; Behfar Ehdaie; Jonathan A Coleman; James A Eastham; Jaspreet S Sandhu
Journal:  Urology       Date:  2021-02-02       Impact factor: 2.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.